Skip to content

Categoryadjuvant

Novel vaccine decreases recurrence in HER2 breast cancer patients.

A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients when it is … Continue Reading Novel vaccine decreases recurrence in HER2 breast cancer patients.

Translate »